Old North State Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Old North State Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-385	Closed	-$4K	–	360
2021 Q1	$4K	Sell	385 -217	-36%	-$2.49K	﹤0.01%	320
2020 Q4	$6K	Hold	602	–	–	﹤0.01%	334
2020 Q3	$5K	Buy	+602	New	+$6.37K	﹤0.01%	319
2020 Q1	–	Sell	-602	Closed	-$6K	–	291
2019 Q4	$6K	Sell	602 -197	-25%	-$1.76K	﹤0.01%	316
2019 Q3	$5K	Hold	799	–	–	﹤0.01%	346
2019 Q2	$7K	Hold	799	–	–	0.01%	318
2019 Q1	$12K	Buy	799 +414	+108%	+$7.3K	0.01%	295
2018 Q4	$5K	Sell	385 -105	-21%	-$2.15K	0.01%	338
2018 Q3	$10K	Buy	+490	New	+$11.4K	0.01%	314

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Old North State Trust's TEVA Position: Q2 2021 in Review

Old North State Trust sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 385 shares — an estimated $4K sold.

Old North State Trust first reported a position in TEVA in Q3 2018 and held it in 9 quarters. The position peaked at $12K in Q1 2019. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

Old North State Trust reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Old North State Trust sold 385 Teva Pharmaceuticals shares in Q2 2021, an estimated $4K.
Old North State Trust first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 9 quarters.
Old North State Trust's Teva Pharmaceuticals position peaked at $12K in Q1 2019.
440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Old North State Trust's 13F filing for Q2 2021, filed 28 Jul 2021.